A B S T R A C T The effect of phytohemagglutinin (PHA) on the ability of human lymphocytes to transport the nonutilizable amino acid, a-aminoisobutyric acid (AIB) has been studied. PHA binds rapidly to plasma membrane receptor sites with half maximal binding requiring approximately 7.5 min. During the first 30 min after PHA addition to lymphocytes no change was detected in AIB transport, but then a linear increase in the initial rate of AIB transport occurred over the next 9 hr. Subsequently, the rate of AIB transport stabilized at a level 6-7 times greater than that found in control lymphocytes. The change in membrane function developed even when de novo protein synthesis was inhibited by 85-90% with puromycin or cycloheximide. However, the PHA effect did not occur when the lymphocytes were maintained at 4VC.
INTRODUCTION
When phytohemagglutinin, a glycoprotein derived from the red kidney bean, is incubated with small lymphocytes, they undergo a series of metabolic changes resulting in morphologic transformation and mitosis. The mechanism whereby PHA1 stimulates lymphocytes to undergo mitosis is unknown. While numerous investigators have studied a variety of metabolic alterations which occur after lymphocytes are exposed to PHA (for a recent review see Reference 1) , little attention has been focused on the effect that PHA may have on the lymphocyte plasma membrane. Recently, Fisher and Mueller (2) have reported that within minutes after PHA is added to lymphocytes there is an increase in the rate of 8P incorporation into membrane phospholipids. However, the consequences of PHA binding to lymphocytes on the functional characteristics of the plasma membrane need to be further explored. Therefore we have investigated the effect of PHA on a membranemediated process, namely the uptake of a-aminoisobutyric acid, a nonutilizable amino acid (3).
METHODS
Bacto-phytohemagglutinin P was obtained from Difco Laboratories, Detroit, Mich. Dextran-grade H with a mol wt of approximately 180,000 was purchased from Pharmachem Corporation, Bethlehem, Pa. Ficoll (mol wt of approximately 400,000), crystallized bovine serum albumin, and puromycin 'dihydrochloride grade II were obtained from Sigma Chemical Company, St. Louis, Mo. Winthrop Laboratories, New York, was the source of sodium diatrizoate (Hypaque). Eagle's minimal essential medium for suspension ' Abbreviations used in this paper: PHA, phytohemagglutinin; AIB, a-aminoisobutyric acid.
cultures (4) , fetal calf serum, and fetuin (Spiro Method) were purchased from Grand Island Biological Company.
The fetuin was dialyzed against 0.9%o NaCl prior to use. Cycloheximide came from Nutritional Biochemicals Corporation. New England Nuclear Corp., Boston, Mass. was the source of a-aminoisobutyric--_14C acid, uridine-5-3H, and thymidine-methyl-3H. Reagent grade "~'I was purchased from Mallinckrodt Chemical Works, St. Louis, Mo.
Preparation of PHA. Difco PHA-P was further purified by sequential SE-Sephadex G-50 column chromatography and Sephadex G-150 gel filtration according to the method of Weber, Nordman, and Grasbeck (5) . The erythroagglutinating PHA (Peak III of Weber et al.), which gave a single broad band on disc gel electrophoresis, was used in all incubation studies with lymphocyte cultures. The material is a potent mitogen. This PHA was iodinated with 1311 by the chloramine-T method of Hunter (6) .
Preparation of lymphocytes. In order to obtain peripheral blood lymphocytes as free as possible from contamination with granulocytes, monocytes, erythrocytes, and platelets the following procedure was devised (Fig. 1 ). Blood donors were normal subjects on no medications and without recent coffee intake. Approximately 100-400 ml of blood were collected in 50 ml plastic syringes using sterile precautions in subsequent steps only in experiments of greater than 12 hr duration. The blood was defibrinated by continuous rotation for 5 min in a 500 ml Erlenmeyer flask containing a dozen 6 mm glass beads. This procedure eliminates platelets, which are taken up in the clot. * volume of saline containing 6 gm of dextran per 100 ml was added, and the blood was then allowed to settle for 1 hr at 370C in 100 ml graduated cylinders (7) . The serum-dextran layers, enriched for leukocytes, were removed, pooled, and mixed with 2 volumes of saline. 36 ml portions were layered over 9 ml of the following solution in a 50 ml conical glass centrifuge tube: 1.80 ml Hypaque 50% weight per volume, 6.35 ml Ficoll 9 g per 100 ml water, and 0.85 ml water (8, 9) . Isopycnic centrifugation was performed at room temperature in an International PR-2 centrifuge (International Equip, Needham Heights, Mass.) at 500 g for 40 min, or in later experiments at 1500 g for 10 min with no decrease in yield of lymphocytes. The white fluffy interface layer between the dextran-serum phase and the Ficoll-Hypaque phase was removed by aspiration. This layer contained 75-92%o lymphocytes, with 8-25% granulocytes and monocytes and 1-8%o contamination with erythrocytes. The cells were then washed twice with saline by centrifugation at 500 g for 5 min and resuspended in 10 ml of the donor's fresh serum. The suspension was poured through a nylon fiber column packed in a 40 ml syringe and eluted with 100 ml minimal essential medium (10) . The eluted cells were harvested by centrifugation and resuspended in the incubation medium (see below) at a cell concentration of 5 X 101-2 X 107 cells per ml. Differential counts showed 99-100%o lymphocytes with the remaining nucleated cells consisting of monocytes or granulocytes. The ratio of RBC: WBC was 1: 100 and platelets were not present. The recovery of lymphocytes was 30-50%o. The entire procedure required 3-4 hr.
Lymphocyte incubation studies. For short term experiments lasting up to 12 hr, the incubation medium consisted of minimal essential medium containing albumin 3 g per 100 ml, glutamine 4 mm, penicillin 5,000 U per 100 ml, and streptomycin 5,000 4tug per 100 ml. For experiments of longer duration, the albumin was replaced with 7.5%o fetal calf serum. Lymphocytes suspended in incubation medium were distributed in 0.2 ml portions into 15 ml conical glass cen- Uptake of AIB. The uptake of AIB by lymphocytes proceeded at a linear rate for more than 20 min in cultures exposed to PHA and in control cultures. The effect of exposing lymphocytes to PHA for varying periods of time on the initial rate of AIB uptake is shown in Fig. 3 . After a lag period of about 30 min, the cells incubated with PHA undergo a linear increase in the initial rate of AIB uptake, which reaches a plateau level after about 10 hr. In contrast, the initial rate of AIB uptake by control lymphocytes is constant over a 20-hr period. The extent of the PHA effect on AIB uptake is dependent on the concentration of PHA in the media (Fig. 4) , with the half maximal effect occurring at a PHA concentration of about 4 jlg per ml.
In addition to the aforementioned studies of the initial rate of AIB transport, experiments were performed to measure the accumulation of AIB by cells continuously exposed to AIB. The uptake of AIB by both control and PHA-treated cells did not reach equilibrium for about 6-8 hr (Fig. 5) In order to characterize the kinetics of AIB uptake in the presence and absence of PHA, the studies shown in Fig. 6 were performed. In Fig. 6A , it is evident that the rate of uptake of AIB follows typical saturation kinetics both in the presence and absence of PHA. When these data were plotted according to Lineweaver and Burk (13) (Fig. 6B) Effect of protein synthesis inhibition on PHA effect. Lymphocyte cultures were preincubated with puromycin in doses that were shown in preliminary experiments to inhibit "4C-amino acid incorporation into protein by more than 90%. Over a period of 2 hr, puromycin caused no alteration in the PHA-induced increase in AIB uptake (Fig. 7) . Likewise, preincubation with cycloheximide at concentrations that inhibited protein synthesis in lymphocytes by more than 85% produced no reduction in the augmented uptake of AIB (Fig. 7) AlBmM FIGURE 6 Uptake of AIB by control (-) and PHA stimulated (0) lymphocytes as a function of AIB concentration. Cultures containing 1.5 X 100 lymphocytes were incubated for 7 hr with or without 20 lAg per ml PHA. The cells were then exposed to varying concentrations of`4C-AIB for 15 min, and harvested for determination of isotope uptake as described. The data shown are from one of three similar experiments.
at 00C and then warmed to 370C just prior to the AIB pulse showed only a 1.1-fold increase in the rate of AIB uptake. The mechanism of AIB transport was further characterized by incubating lymphocytes with unlabeled 1mM AIB prior to measurement of the rate of uptake of 14C-AIB (Table I ). The preincubation period produced no alteration in the rate of AIB uptake either in the presence or absence of PHA indicating an absence of exchange diffusion. 2 Removal of PHA from lymphocytes. Having demonstrated that PHA can alter the membrane function of lymphocytes, we next investigated whether this effect would be sustained or reversed when the bound PHA was removed from the lymphocyte cell surface. In pre-2 The term "exchange diffusion" is used to indicate the exchange of labeled and unlabeled molecules of the same species across the cell membrane without concomitant net flow (14 Release of "I-PHA bound to lymphocytes by addition of fetuin. Cultures containing 3 X 10' lymphocytes were incubated with 11 jug per ml l'1I-PHA (8 X 10' cpm per ,ug) in a volume of 0.4 ml. After 1 and 3 hr fetuin was added at the concentrations noted below and the incubations were allowed to proceed. At the indicated times paired cultures were harvested and washed, and the amount of lI-PHA bound to the cells was determined. * -2 mg fetuin; 0 -0.5 mg fetuin; 0 -no fetuin.
lymphocytes were then incubated at 37°C, 20% more of the PHA was released into the medium over a 2-3 hr period. These findings show that the PHA is tightly bound to the cell membrane. In previous studies we had demonstrated that the carbohydrate side-chains of fetuin have a structure somewhat similar to those of the erythrocyte membrane receptor sites for PHA (15) . Further, we had shown that fetuin is a potent inhibitor of PHA binding to erythrocytes. As shown in Fig. 8 , fetuin was capable of rapidly removing bound PHA from lymphocytes, even after the PHA had been in contact with the cells for 3 hr. The absolute amount of PHA removed was dependent on the concentration of PHA and fetuin in the medium. At a PHA concentration of 10 ig per ml, it required 5 mg per ml fetuin to remove 80% of the bound PHA (Fig. 8) .
Effect of PHA removal from lymphocytes on AIB uptake. In a series of experiments, lymphocytes were incubated with PHA for various periods of time and then fetuin was added to remove the bound PHA. The effect of fetuin addition on the rate of AIB uptake was then determined. As shown in Fig. 9 , when fetuin was added to lymphocyte cultures which had been exposed to PHA for 2 hr, the increased rate of AIB uptake was arrested at the rate reached after the 2 hr of exposure to PHA. This rate of AIB uptake was then maintained for the next 3 hr following PHA removal. In contrast, the cultures continuously exposed to PHA for the entire 5 hr period of the experiment showed the usual continued rise in the rate of AIB uptake. In experiments with lower concentrations of fetuin, a lesser degree of inhibition was observed.
Fetuin blocks the PHA effect on AIB transport by its interaction with PHA rather than by exerting a non- specific toxic effect, as shown in Table II . Thus, when control lymphocyte cultures not exposed to PHA were incubated with fetuin for 4 hr they exhibited a slight stimulation in the rate of AIB uptake. If the fetuin had been toxic one would have expected the AIB uptake to be depressed. Furthermore, in the case of PHA-stimulated cultures, by increasing the concentration of PHA the inhibitory effect of fetuin was progressively overcome, showing the competitive nature of the reaction.
To prove that fetuin could be incubated with lymphocytes for long periods of time without causing toxic effects, the experiment shown in Table III was performed. The ability of control lymphocytes to synthesize DNA at the end of a 3-day incubation was not significantly affected by the addition of fetuin at a concentration of 3.75 mg per ml. Further, while fetuin was a potent inhibitor of the mitogenic response of lymphocytes induced by PHA, the inhibition could be overcome by increasing the concentration of PHA in the cultures. The fact that fetuin inhibits the PHA-induced mitogenic response provides evidence that its effect on AIB uptake is not an isolated phenomenon but rather related to its ability to remove PHA from the lymphocyte surface. With fetuin concentrations greater than 5 mg/ml, a suppression of 'H-thymidine incorporation into DNA in control cultures was observed.
DISCUSSION
We have demonstrated that PHA induces a profound alteration in at least one functional property of the (26) .
The studies on the kinetics of AIB uptake by control and PHA-treated lymphocytes demonstrate that PHA increases the V.ax of AIB uptake without affecting the Km of the transport system. This change in the V.a. could result from an increased rate of transport by each site, or from the induction of an increased number of sites for AIB transport. Previously Helmreich and Kipnis (14) , studying the transport of AIB by guinea pig and rabbit lymph node cells, found that at low concentrations of AIB (up to 0.1 mM) uptake occurred by an active transport process exhibiting saturation kinetics with an apparent Michaelis constant of 0.11 mm. At higher concentrations of AIB, uptake occurred by a first order process with characteristics of diffusion. Our findings differ from these in that we do not detect significant diffusion of AIB into the cells at concentrations of AIB as high as 5 mm and further, the Km for AIB binding in our system is 2 mm. One major difference in these studies is that we have used human peripheral blood lymphocytes which were processed in a fashion quite different from that employed by Helmreich and Kipnis. The failure to demonstrate exchange diffusion in human lymphocytes is in agreement with the data of these investigators utilizing guinea pig and rabbit lymph node cells. Studies of AIB transport by 3T3 cells (27) and renal tubule cells (28) have yielded Km's in a range similar to our value of 2 mm obtained for human lymphocytes. In the studies of Foster and Pardee (27) the rate of AIB uptake by polyoma virus-transformed 3T3 cells was found to vary with their growth conditions. Thus AIB was accumulated about 30% less rapidly by confluent than by nonconfluent 3T3 cells in tissue culture.
The effect of PHA on AIB uptake differs in several ways from its effect on uridine uptake, as previously described by Lucas (29) and by Hausen and Stein (30) . These investigators found that the stimulation of uridine incorporation into RNA which steadily increased during the first 24 hr of exposure to PHA was accompanied by a progressive rise in the concentration of uridine nucleotides in the soluble intracellular pool. Further, the enhanced uptake of uridine was shown to occur concomitant with a rise in uridine kinase activity. When uridine kinase was selectively inhibited by adding cytidine to the media, the uptake of uridine into RNA was also inhibited (29) . These authors suggested that the rate limiting step in uridine uptake may be the phosphorylation of uridine by uridine kinase rather than an actual change in active transport of uridine through the cell membrane. A similar phenomenon cannot account for the enhanced uptake of AIB by lymphocytes since it is a nonmetabolizable amino acid (3). Hausen and Stein also showed that PHA stimulates thymidine uptake into the soluble intracellular pool only after a lag period of 20-24 hr which correlates well with the time at which PHA induced DNA synthesis is first demonstrable. The fact that PHA stimulates the uptake of AIB, uridine and thymidine at very different times after its addition makes it unlikely that PHA is inducing a nonspecific increase in membrane permeability. Consistent with this proposal is our finding that the rate of uptake of inulin (mol wt about 5,000) is not affected by PHA.'
